DK1513878T3 - Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 - Google Patents

Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100

Info

Publication number
DK1513878T3
DK1513878T3 DK03748180T DK03748180T DK1513878T3 DK 1513878 T3 DK1513878 T3 DK 1513878T3 DK 03748180 T DK03748180 T DK 03748180T DK 03748180 T DK03748180 T DK 03748180T DK 1513878 T3 DK1513878 T3 DK 1513878T3
Authority
DK
Denmark
Prior art keywords
apo
apolipoprotein
methods
concerns
compositions
Prior art date
Application number
DK03748180T
Other languages
Danish (da)
English (en)
Inventor
Jamila Najib
Zouher Majd
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit filed Critical Genfit
Application granted granted Critical
Publication of DK1513878T3 publication Critical patent/DK1513878T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Light Receiving Elements (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03748180T 2002-06-19 2003-06-19 Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 DK1513878T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207542A FR2841249A1 (fr) 2002-06-19 2002-06-19 Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100
PCT/FR2003/001888 WO2004000884A2 (fr) 2002-06-19 2003-06-19 Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100

Publications (1)

Publication Number Publication Date
DK1513878T3 true DK1513878T3 (da) 2007-07-16

Family

ID=29719858

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03748180T DK1513878T3 (da) 2002-06-19 2003-06-19 Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100

Country Status (11)

Country Link
US (1) US20050152900A1 (de)
EP (1) EP1513878B1 (de)
JP (1) JP2006515561A (de)
AT (1) ATE356832T1 (de)
AU (1) AU2003267493A1 (de)
CA (1) CA2489057A1 (de)
DE (1) DE60312513T2 (de)
DK (1) DK1513878T3 (de)
ES (1) ES2283803T3 (de)
FR (1) FR2841249A1 (de)
WO (1) WO2004000884A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1957255A (zh) * 2004-03-29 2007-05-02 株式会社芝山羊 用于测定载脂蛋白b－48的方法及其应用
WO2007058588A1 (en) * 2005-11-18 2007-05-24 T.A.C Thrombosis And Coagulation Aktiebolag Monoclonal antibodies against apolipoprotein m
MX2008012135A (es) * 2006-03-23 2009-03-12 Emelita De Guzman Breyer Tecnica de identificacion genetica de apolipoproteina.
CA3170924A1 (en) 2007-10-02 2009-04-09 Labrador Diagnostics Llc Modular point-of-care devices and uses thereof
JP5832723B2 (ja) * 2009-03-06 2015-12-16 協和メデックス株式会社 可溶性インターロイキン−２受容体定量用標準品
CN102439035A (zh) * 2009-03-17 2012-05-02 佛斯卡专利公司 治疗和/或预防动脉粥样硬化的免疫调节方法和系统，以及相关蛋白、肽和组合物
EP2499488A1 (de) 2009-11-14 2012-09-19 Kuang-Yuh Chyu Immunmodulatorische verfahren und systeme zur behandlung und/oder prävention von atherosklerose
US8506964B2 (en) * 2010-02-05 2013-08-13 Cardiovax, Llc Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
EP2637689A2 (de) 2010-11-12 2013-09-18 Cedars-Sinai Medical Center Immunmodulatorische verfahren und systeme zur behandlung und/oder prävention von bluthochdruck
CN103501806A (zh) 2010-11-12 2014-01-08 赛达斯西奈医疗中心 用于治疗和/或预防动脉瘤的免疫调节方法和系统
CN106290160A (zh) 2011-01-21 2017-01-04 提拉诺斯公司 样品使用最大化的系统和方法
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US11008628B1 (en) * 2013-02-18 2021-05-18 Labrador Diagnostics Llc Systems and methods for analyte testing and laboratory oversight
US10401373B1 (en) 2013-02-18 2019-09-03 Theranos Ip Company, Llc Systems and methods for analyte testing and laboratory oversight
US10422806B1 (en) 2013-07-25 2019-09-24 Theranos Ip Company, Llc Methods for improving assays of biological samples
US11360107B1 (en) 2014-02-25 2022-06-14 Labrador Diagnostics Llc Systems and methods for sample handling
CN106053793A (zh) * 2016-06-20 2016-10-26 诺莱生物医学研究院（北京）有限公司 一种快速检测乳糜血的免疫层析试纸卡及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60193926A (ja) * 1984-03-15 1985-10-02 Tokyo Daigaku 単クローン性抗ヒトアポリポ蛋白質ｂ１００抗体
JPS617299A (ja) * 1984-06-20 1986-01-13 Dai Ichi Pure Chem Co Ltd ヒトアポリポ蛋白ｂ４８に高い特異性を有する単クローン性抗体
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors

Also Published As

Publication number Publication date
JP2006515561A (ja) 2006-06-01
CA2489057A1 (fr) 2003-12-31
FR2841249A1 (fr) 2003-12-26
US20050152900A1 (en) 2005-07-14
AU2003267493A1 (en) 2004-01-06
EP1513878A2 (de) 2005-03-16
DE60312513T2 (de) 2007-12-06
DE60312513D1 (de) 2007-04-26
WO2004000884A3 (fr) 2004-04-08
WO2004000884A2 (fr) 2003-12-31
EP1513878B1 (de) 2007-03-14
ES2283803T3 (es) 2007-11-01
ATE356832T1 (de) 2007-04-15

Similar Documents

Publication Publication Date Title
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
AU2003243558A1 (en) Test strip for detection of analyte and methods of use
WO2003106964A3 (en) HIGH EFFICIENCY METHODS AND DEVICES FOR ASSAYING ANALYTES IN A FLUID SAMPLE
EP1312919A3 (de) Probevolumen-Messapparat
BR9710836A (pt) Ensaio de analitos usando marcas em partìculas
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
EP1359417A3 (de) Vorrichtung und Methode zur Bestimmung einer Analytkonzentration
IL157380A0 (en) Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
ATE449963T1 (de) Immunoassays unter verwendung von sers (surface enhanced raman scattering)
MXPA02010106A (es) Determinacion de suficiencia de volumen de muestra en dispositivos biosensores.
AU2002350779A1 (en) Analyzer and analysing method and a fluid cartridge
TW200606420A (en) Biosensors having improved sample application and uses thereof
KR970701789A (ko) 콜레스테롤의 정량방법(method for quantitatively determining cholesterol)
ATE522812T1 (de) Verfahren und zusammensetzung zum bestimmen von homocystein
DE60204418D1 (de) "High-Density-Lipoprotein"-Testvorrichtung und Verfahren
WO2004042403A3 (en) Methods, device and instrument for detection of analytes
DE60318435D1 (de) Universeller biosensor und verfahren zur verwendung
WO2004079343A3 (en) Sample preparation for colorimetric and fluorescent assays as implemented on optical analysis discs
WO2002077645A3 (en) Method for the measurement of soluble analytes
WO2002059600A3 (en) Analyte detection
WO2002014869A3 (en) Assay method and device for detecting the presence and concentration of analytes
DK1423708T3 (da) Sammensætninger og fremgangsmåder til bestemmelser af AA4RP
ATE274702T1 (de) Verwendung derivatisierter reagenzien in chemilumineszenz- und elektrochemilumineszenz- nachweisverfahren